The English used in this article may not be easy for everybody to understand. (March 2018)
|Industry||Research and Development|
|Founded||February 24, 2010|
|Founder||Dr. Frank. F. Craig, Professor Wilhelm Huck, Professor Chris Abell and Dr. Maher Khaled|
|Services||biochemical and anti-micobial screening, synthetic biology, genome editing of single cells.|
Sphere Fluidics is an England-based Life Sciences Research and Development company specializing in developing novel tools for biopharmaceutical discovery and development, cell therapy engineering, analysis and isolation. Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business in 2015.
History[change | change source]
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of Cambridge University, namely, Professor Chris Abell and Professor Wilhelm Huck along with Dr. Frank F. Craig, an entrepreneur, and Dr. Maher Khaled, a Cambridge University Enterprise.
In 2013, Sphere Fluidics spun out of Cambridge University to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.
Overview[change | change source]
Sphere Fluidics operates in various markets including biopharmaceutical discovery and development, anti-microbial screening, synthetic biology and genome editing of single cells. 
Funding[change | change source]
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket, Amadeus Capital Partners, Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels, Envestors, Angels5K, Cambridge Angels, Q-Ventures and a Japanese corporate investor.
Cyto-Mine Technology[change | change source]
Cyto-Mine technology is the integrated device that is able to automatically perform single cell analysis, sorting, imaging and dispensing into individual wells of microtitre plates in a single compact system. Based on the research made by Professors Chris Abell and Wilhelm Huck, this biochip system can automatically process millions to billions of miniaturised tests in tiny picodroplets.
According to the scientists at Sphere Fluidics, Cyto-Mine can perform millions of single-cell assays daily, offering up to a 100-fold improvement over conventional techniques, at lower capital and operational cost. 
References[change | change source]
- "Sphere Fluidics Raises $7 Million for Development Of Cyto-Mine Single Cell Analysis System - SynBioBeta". synbiobeta.com. Retrieved 2017-09-13.
- site., Who made this. "Sphere Fluidics named one of Britain's most disruptive businesses - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
- "From farm to fame, Cambridge's 'cereal' life science entrepreneur | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
- "Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business". Real Business. 2015-03-04. Retrieved 2017-09-13.
- site., Who made this. "Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
- "Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online". www.labmate-online.com. Retrieved 2017-09-13.
- Dealmakers, BioPharma (2017-01-24). "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products". BioPharma Dealmakers. Retrieved 2017-09-13.
- "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News". Scientific Technology News. 2017-01-24. Retrieved 2017-09-13.
- "Angels on the side of Cambridge trio | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
- "UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment | Crowdfund Insider". Crowdfund Insider. 2017-07-08. Retrieved 2017-09-13.
- "Investment flows towards Sphere Fluidics · Articles · Global University Venturing". www.globaluniversityventuring.com. Retrieved 2017-09-13.
- "London Business Angels investment helps Sphere Fluidics close £1.6m early stage funding round". Business Matters. 2013-03-10. Retrieved 2017-09-13.
- "Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK". www.gov.uk. Retrieved 2017-09-13.
- "Sphere Fluidics successfully closes a £1.6 million Series A investment round". Cambridge Network. Retrieved 2017-09-13.
- "Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"! | Evaluate". www.evaluategroup.com. Retrieved 2017-09-13.
- site., Who made this. "Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.